C43H46F3N9O6 — CID 171767653
N-[[4-[2-[2-[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propyl]piperazin-1-yl]pyrimidin-4-yl]-1,3-oxazol-5-yl]-1-bicyclo[2.2.2]octanyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide (PubChem CID 171767653) has the molecular formula C43H46F3N9O6 and a molecular weight of 841.89 g/mol. Its IUPAC name is N-[[4-[2-[2-[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propyl]piperazin-1-yl]pyrimidin-4-yl]-1,3-oxazol-5-yl]-1-bicyclo[2.2.2]octanyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide.
| Compound Name | N-[[4-[2-[2-[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propyl]piperazin-1-yl]pyrimidin-4-yl]-1,3-oxazol-5-yl]-1-bicyclo[2.2.2]octanyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide |
|---|---|
| PubChem CID | 171767653 |
| Molecular Formula | C43H46F3N9O6 |
| Molecular Weight | 841.89 g/mol |
| Exact Mass | 841.35 |
| IUPAC Name | N-[[4-[2-[2-[4-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propyl]piperazin-1-yl]pyrimidin-4-yl]-1,3-oxazol-5-yl]-1-bicyclo[2.2.2]octanyl]methyl]-2,3,5-trifluoro-4-hydroxybenzamide |
| SMILES | Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCCN3CCN(c4nccc(-c5ncc(C67CCC(CNC(=O)c8cc(F)c(O)c(F)c8F)(CC6)CC7)o5)n4)CC3)cc21 |
| InChI | InChI=1S/C43H46F3N9O6/c1-52-31-21-25(4-5-29(31)55(41(52)60)30-6-7-33(56)51-38(30)59)3-2-16-53-17-19-54(20-18-53)40-47-15-8-28(50-40)39-48-23-32(61-39)43-12-9-42(10-13-43,11-14-43)24-49-37(58)26-22-27(44)36(57)35(46)34(26)45/h4-5,8,15,21-23,30,57H,2-3,6-7,9-14,16-20,24H2,1H3,(H,49,58)(H,51,56,59) |
| InChIKey | VDSSYIAOBJUGAF-UHFFFAOYSA-N |
| XLogP | 4.66 |
| TPSA | 180.72 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 61 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 841.89 |
| LogP ≤ 5 | 4.66 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 13 |
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|